Fundraising FoxLensGen
Irvine, US · Founded 2011 · Delaware corporation · 1 known investors
Find your way into LensGen
Sign up to see every warm intro you have to LensGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LensGen team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LensGen is an ophthalmic medical device company that has developed Juvene, a curvature-changing fluid-optic intraocular lens designed to treat cataracts and presbyopia. The biomimetic lens is placed in the position of the eye's natural lens and adjusts its dioptric power using the eye's own muscle contractions.
Founders & leadership
LensGen was founded in 2011 by Ramgopal Rao.
RR
Ramgopal RaoFounder & Chief Executive Officer
Board
AF
Akiteru FurukawaBoard director
MC
Michael ColacoBoard director
SG
Shivbir GrewalBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 2 rounds · 2014–2017
▶$7.3MraisedMay 2017 · 13 investors · Other Health CareRule 506(b)
▶$7.3MraisedMay 2017 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Akiteru FurukawaDirector
- Michael ColacoDirector
- Ramgopal RaoExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $7.3M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedDec 2014 · 7 investors · Other Health CareRule 506(b)
▶$300KraisedDec 2014 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ramgopal RaoExecutive Officer, Director
- Michael ColacoDirector
- Shivbir GrewalDirector
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
OisOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies working in the same space as LensGen.
In the news
Frequently asked questions
- What does LensGen do?
- LensGen is an ophthalmic medical device company that has developed Juvene, a curvature-changing fluid-optic intraocular lens designed to treat cataracts and presbyopia. The biomimetic lens is placed in the position of the eye's natural lens and adjusts its dioptric power using the eye's own muscle contractions.
- Who founded LensGen?
- LensGen was founded by Ramgopal Rao in 2011.
- Who are LensGen's investors?
- LensGen's investors include ExSight Ventures.
- How much funding has LensGen raised?
- LensGen has disclosed $7.6M raised across 2 rounds.
- Where is LensGen headquartered?
- LensGen is headquartered in Irvine, US.